Nova Allegro UACR Assay, Nova Allegro Analyzer— 510(k) K252206

Substantially Equivalent

Nova Biomedical Corporation

FDA 510(k) clearance K252206 for Nova Allegro UACR Assay, Nova Allegro Analyzer, Substantially Equivalent on 2026-01-09. Applicant: Nova Biomedical Corporation.

Clearance details

Applicant
Nova Biomedical Corporation
Product code
Code CGX
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Dual Track
Location
Walham, MA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.